MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce that its wholly owned subsidiary, MediPharm Labs Inc., has entered into purchase agreements to secure a substantial 9,000 KG of dried cannabis supply from […]
The post MediPharm Labs Secures 9,000 KG of Dried Cannabis Adding Substantial Private Label Cannabis Extract Production appeared first on Technical420.
You may also like
-
Are These Safer Ways To Invest In Marijuana Stocks?
-
When Will Chuck Schumer Be Ready With His Cannabis Reform Bill?
-
Tilray Board of Directors Announces Approval of Amendment to Company’s Bylaws; Aphria and Tilray Announce Waiver of Charter Amendment Proposal Requirement
-
Best Marijuana Stock To Buy? Top Pot Stocks To Watch For Next Week
-
Tilray, Inc. (TLRY) Board of Directors Announces Approval of Amendment to Company’s Bylaws